Physician profile
Aaron T Wolf
NPI 1427289545
$5,198.91
in general payments reported to CMS, 2019-2025
24 companies · $460 in 2025
The $460 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $775 · 2020: $252 · 2021: $157 · 2022: $2,615 · 2023: $249 · 2024: $691 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.88 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,150.31 | 2019-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $422.67 | 2024-2025 | Xdemvy |
| Rxsight INC | $327.42 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $306.52 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $282.02 | 2019 | |
| Coopervision INC. | $211.40 | 2022-2025 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $211.07 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $163.26 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $145.68 | 2020-2023 | |
| Sight Sciences, INC. | $144.94 | 2022 | |
| Allergan, INC. | $134.63 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $113.26 | 2019-2020 | |
| Horizon Therapeutics Plc | $108.68 | 2022 | |
| Abb Con-Cise Optical Group LLC | $99.13 | 2021-2024 | Spectacle Lenses, Contact Lens |
| Synergeyes, INC. | $98.78 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $61.83 | 2021-2022 | |
| Alcon Vision LLC | $57.31 | 2023 | Clareon |
| Carl Zeiss Meditec USA, INC. | $32.30 | 2022 | |
| Kala Pharmaceuticals, INC. | $27.03 | 2022 | |
| Abbvie INC. | $26.88 | 2022 | |
| Oyster Point Pharma, INC. | $20.54 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Dompe US, INC. | $16.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.